Tiziana Life Sciences Ltd (TLSA)
0.70
+0.04
(+5.67%)
USD |
NASDAQ |
May 02, 16:00
0.6803
-0.02
(-2.81%)
After-Hours: 18:52
Tiziana Life Sciences Max Drawdown (5Y): 96.99% for April 30, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| April 30, 2024 | 96.99% |
| March 31, 2024 | 96.99% |
| February 29, 2024 | 96.53% |
| January 31, 2024 | 96.32% |
| December 31, 2023 | 96.32% |
| November 30, 2023 | 96.32% |
| October 31, 2023 | 96.32% |
| September 30, 2023 | 96.32% |
| August 31, 2023 | 96.32% |
| July 31, 2023 | 96.32% |
| June 30, 2023 | 96.32% |
| May 31, 2023 | 96.32% |
| April 30, 2023 | 96.32% |
| March 31, 2023 | 96.32% |
| February 28, 2023 | 96.10% |
| January 31, 2023 | 96.03% |
| December 31, 2022 | 96.03% |
| November 30, 2022 | 96.03% |
| October 31, 2022 | 96.03% |
| September 30, 2022 | 96.03% |
| August 31, 2022 | 95.52% |
| July 31, 2022 | 95.52% |
| June 30, 2022 | 95.52% |
| May 31, 2022 | 95.52% |
| April 30, 2022 | 95.52% |
| Date | Value |
|---|---|
| March 31, 2022 | 95.52% |
| February 28, 2022 | 95.52% |
| January 31, 2022 | 94.30% |
| December 31, 2021 | 93.58% |
| November 30, 2021 | 90.98% |
| October 31, 2021 | 89.17% |
| September 30, 2021 | 79.07% |
| August 31, 2021 | 78.06% |
| July 31, 2021 | 73.80% |
| June 30, 2021 | 73.39% |
| May 31, 2021 | 73.39% |
| April 30, 2021 | 73.39% |
| March 31, 2021 | 73.39% |
| February 28, 2021 | 73.39% |
| January 31, 2021 | 73.39% |
| December 31, 2020 | 73.39% |
| November 30, 2020 | 68.27% |
| October 31, 2020 | 68.27% |
| September 30, 2020 | 68.27% |
| August 31, 2020 | 68.27% |
| July 31, 2020 | 68.27% |
| June 30, 2020 | 68.27% |
| May 31, 2020 | 68.27% |
| April 30, 2020 | 68.27% |
| March 31, 2020 | 68.27% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
52.79%
Minimum
May 2019
96.99%
Maximum
Mar 2024
82.07%
Average
90.08%
Median
Max Drawdown (5Y) Benchmarks
| Altamira Therapeutics Ltd | 99.96% |
| Kiniksa Pharmaceuticals Ltd | 83.06% |
| UnitedHealth Group Inc | 35.92% |
| BeiGene Ltd | 69.96% |
| CEL-SCI Corp | 96.13% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -34.35 |
| Beta (5Y) | 0.4345 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 104.7% |
| Historical Sharpe Ratio (5Y) | -0.282 |
| Historical Sortino (5Y) | -0.726 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 34.56% |